Literature DB >> 23275015

In vitro bactericidal activity of Jinghua Weikang Capsule and its individual herb Chenopodium ambrosioides L. against antibiotic-resistant Helicobacter pylori.

Wei Liu1, Yu Liu, Xue-Zhi Zhang, Ning Li, Hong Cheng.   

Abstract

OBJECTIVE: To investigate the bactericidal effects of Jinghua Weikang Capsule and its major component Chenopodium ambrosioides L. on antibiotic-resistant Helicobacter pylori.
METHODS: Four clinical antibiotic-resistant H. pylori strains were isolated and incubated in liquid medium containing Jinghua Weikang Capsule or Chenopodium ambrosioides L. By means of time-kill curve method, the average colony counts and bactericidal rate were calculated at time points of 0, 4, 8 and 24 h after the incubation and the time-kill curves were charted.
RESULTS: Both Jinghua Weikang Capsule and Chenopodium ambrosioides L. at a concentration of 0.64 g/L showed obvious bactericidal effect against antibiotic-resistant H. pylori after 4 h of incubation.
CONCLUSION: Jinghua Weikang Capsule and Chenopodium ambrosioides L. are considered to be active against antibiotic-resistant H. pylori in vitro.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23275015     DOI: 10.1007/s11655-012-1248-y

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  7 in total

Review 1.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? A 10 years' endoscopical survey.

Authors:  Giorgio Nervi; Stefania Liatopoulou; Lucas-Giovanni Cavallaro; Alessandro Gnocchi; Nadia Dal-Bo; Massimo Rugge; Veronica Iori; Giulia-Martina Cavestro; Marta Maino; Giancarlo Colla; Angelo Franze; Francesco Di Mario
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

3.  Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.

Authors:  W Fischbach; M-E Goebeler-Kolve; B Dragosics; A Greiner; M Stolte
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

4.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

Authors:  Benjamin Chun-Yu Wong; Shiu Kum Lam; Wai Man Wong; Jian Shun Chen; Ting Ting Zheng; Rui E Feng; Kam Chuen Lai; Wayne Hsing Cheng Hu; Siu Tsan Yuen; Suet Yi Leung; Daniel Yee Tak Fong; Joanna Ho; Chi Kong Ching; Jun Shi Chen
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

Review 5.  The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria.

Authors:  Daniel G Federman; Robert S Kirsner; John P Moriarty; John Concato
Journal:  J Am Acad Dermatol       Date:  2003-11       Impact factor: 11.527

Review 6.  Helicobacter pylori infection in gastric cancerogenesis.

Authors:  P C Konturek; S J Konturek; T Brzozowski
Journal:  J Physiol Pharmacol       Date:  2009-09       Impact factor: 3.011

7.  Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients.

Authors:  Hiroto Miwa; Nobuhiro Sakaki; Kentaro Sugano; Hitoshi Sekine; Kazuhide Higuchi; Naomi Uemura; Mototsugu Kato; Kazunari Murakami; Chieko Kato; Akiko Shiotani; Toshifumi Ohkusa; Atsushi Takagi; Nobuo Aoyama; Ken Haruma; Kazuichi Okazaki; Kazuo Kusugami; Masayuki Suzuki; Takashi Joh; Takeshi Azuma; Akinori Yanaka; Hidekazu Suzuki; Hiroshi Hashimoto; Takashi Kawai; Toshiro Sugiyama
Journal:  Helicobacter       Date:  2004-02       Impact factor: 5.753

  7 in total
  8 in total

Review 1.  Innovative Perspectives of Integrated Chinese Medicine on H. pylori.

Authors:  Hui Ye; Zong-Ming Shi; Yao Chen; Jing Yu; Xue-Zhi Zhang
Journal:  Chin J Integr Med       Date:  2018-06-08       Impact factor: 1.978

2.  Anti-Helicobacter pylori activities of Chenopodium ambrosioides L. in vitro and in vivo.

Authors:  Hui Ye; Yu Liu; Ning Li; Jing Yu; Hong Cheng; Jiang Li; Xue-Zhi Zhang
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

Review 3.  Evidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: a systematic review.

Authors:  Vinayak Nagaraja; Guy D Eslick
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 4.  Overview of the phytomedicine approaches against Helicobacter pylori.

Authors:  Filipa F Vale; Mónica Oleastro
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

5.  Interaction of ascaridole, carvacrol, and caryophyllene oxide from essential oil of Chenopodium ambrosioides L. with mitochondria in Leishmania and other eukaryotes.

Authors:  Lianet Monzote; Gerald Geroldinger; Matthias Tonner; Ramón Scull; Sritama De Sarkar; Sophie Bergmann; Markus Bacher; Katrin Staniek; Mitali Chatterjee; Thomas Rosenau; Lars Gille
Journal:  Phytother Res       Date:  2018-04-19       Impact factor: 5.878

Review 6.  A Systematic Review of the Mechanisms Underlying Treatment of Gastric Precancerous Lesions by Traditional Chinese Medicine.

Authors:  Liangjun Yang; Jiali Li; Zhipeng Hu; Xiangzhen Fan; Tiantian Cai; Huafeng Pan
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-26       Impact factor: 2.629

7.  Revealing the novel effect of Jinghua Weikang capsule against the antibiotic resistance of Helicobacter pylori.

Authors:  Xiaofen Jia; Qiuyue Huang; Miaomiao Lin; Yingming Chu; Zongming Shi; Xuezhi Zhang; Hui Ye
Journal:  Front Microbiol       Date:  2022-09-06       Impact factor: 6.064

Review 8.  Efficacy of complementary medicine for nonsteroidal anti-inflammatory drug-induced small intestinal injuries: A narrative review.

Authors:  Minji Cho; Youngmin Bu; Jae-Woo Park; Hasanur Rahman; Seok-Jae Ko
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.